Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 433

1.

Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O.

J Natl Cancer Inst. 2009 Feb 18;101(4):248-55. doi: 10.1093/jnci/djn478. Review.

PMID:
19211444
2.

Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials.

Vidal L, Gafter-Gvili A, Salles G, Dreyling MH, Ghielmini M, Hsu Schmitz SF, Pettengell R, Witzens-Harig M, Shpilberg O.

J Natl Cancer Inst. 2011 Dec 7;103(23):1799-806. doi: 10.1093/jnci/djr418. Review.

PMID:
22021664
3.

Rituximab as maintenance therapy for patients with follicular lymphoma.

Vidal L, Gafter-Gvili A, Leibovici L, Shpilberg O.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006552. doi: 10.1002/14651858.CD006552.pub2. Review.

PMID:
19370640
4.

Rituximab maintenance therapy in indolent NHL: a clinical review.

Buske C, Hiddemann W.

Leuk Res. 2006 Mar;30 Suppl 1:S11-5. Review.

PMID:
16750673
5.

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.

Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD007678. doi: 10.1002/14651858.CD007678.pub2. Review.

PMID:
22258971
6.

Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.

Papaioannou D, Rafia R, Rathbone J, Stevenson M, Buckley Woods H, Stevens J.

Health Technol Assess. 2012;16(37):1-253, iii-iv. Review.

7.

Use of rituximab in patients with follicular lymphoma.

Marcus R.

Clin Oncol (R Coll Radiol). 2007 Feb;19(1):38-49. Review.

PMID:
17305253
8.

Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis.

Al Khabori M, de Almeida JR, Guyatt GH, Kuruvilla J, Crump M.

J Natl Cancer Inst. 2012 Jan 4;104(1):18-28. doi: 10.1093/jnci/djr450. Review.

PMID:
22190633
9.

Prolonging remission with rituximab maintenance therapy.

Hainsworth JD.

Semin Oncol. 2004 Feb;31(1 Suppl 2):17-21. Review.

PMID:
15042530
10.

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.

Boland A, Bagust A, Hockenhull J, Davis H, Chu P, Dickson R.

Health Technol Assess. 2009 Sep;13 Suppl 2:41-8. doi: 10.3310/hta13suppl2/06. Review.

11.

Rituximab maintenance therapy in follicular lymphoma.

Forstpointner R, Dreyling M.

Curr Hematol Malig Rep. 2007 Oct;2(4):213-8. doi: 10.1007/s11899-007-0029-8. Review.

PMID:
20425372
12.

Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.

Collins-Burow B, Santos ES.

Expert Rev Anticancer Ther. 2007 Mar;7(3):257-73. Review.

PMID:
17338647
13.

Maintenance therapy for low-grade lymphomas: has the time come?

Cartron G, Solal-Céligny P.

Curr Opin Oncol. 2007 Sep;19(5):425-32. Review.

PMID:
17762565
14.

A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphoma.

Brandt L, Kimby E, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):213-23. Review.

PMID:
11441933
15.

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma.

Schulz H, Bohlius J, Skoetz N, Trelle S, Kober T, Reiser M, Dreyling M, Herold M, Schwarzer G, Hallek M, Engert A.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003805. Review.

PMID:
17943799
16.

Safety of rituximab maintenance therapy in follicular lymphomas.

Solal-Céligny P.

Leuk Res. 2006 Mar;30 Suppl 1:S16-21. Review.

PMID:
16750674
17.

Rituximab maintenance therapy: a step forward in follicular lymphoma.

van Oers MH.

Haematologica. 2007 Jun;92(6):826-33. Review.

18.

Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis.

Ren YR, Jin YD, Zhang ZH, Li L, Wu P.

Chin Med J (Engl). 2015 Feb 5;128(3):378-83. doi: 10.4103/0366-6999.150111. Review.

19.

First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma.

Hainsworth JD.

Semin Oncol. 2003 Feb;30(1 Suppl 2):9-15. Review.

PMID:
12652459
20.

A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma.

Gao G, Liang X, Jiang J, Zhou X, Huang R, Chu Z, Zhan Q.

Acta Oncol. 2010;49(1):3-12. doi: 10.3109/02841860903150502. Review.

PMID:
19714523
Items per page

Supplemental Content

Support Center